The National Academy of Sports Medicine (NASM) has unveiled a groundbreaking course titled “Understanding Weight Loss Medications: A Guide for Fitness and Wellness Professionals.” This course aims to arm fitness experts with essential knowledge about modern weight loss medications, particularly the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) classes. As these medications gain popularity for obesity management, understanding their implications on health and exercise is crucial for trainers guiding their clients through weight loss journeys.
The course investigates the increasing adoption of GLP-1 and GIP medications among U.S. adults, revealing that approximately 8-12% have used these drugs, with 6% actively taking them. Mike Fantigrassi, NASM’s Head of Product, emphasizes the necessity for fitness professionals to be informed about these medications to tailor exercise regimens safely for clients utilizing them.
Delving into both existing and emerging GLP-1/GIP drugs, participants will explore vital aspects such as drug actions, side effects, and specific considerations for safe application in exercise settings. The curriculum equally discusses professionals’ roles in the health framework, equipping them with nutrition strategies, exercise guidance, and behavioural coaching for clients on these medications.
Course objectives encompass several key elements: identifying obesity-related health risks, comparing GLP-1 and GIP medications, recognising their benefits and potential side effects, and establishing comprehensive support systems for clients. Such robust training aligns with NASM’s commitment to evidence-based research in fitness education.
For those eager to delve deeper into this transformative course, more information can be accessed by visiting the NASM website.
NASM launches a new course aimed at educating fitness professionals on weight loss medications, particularly GLP-1 and GIP. The course addresses the rising usage of these drugs and their implications for exercise and health guidance. Key objectives include understanding health risks, comparing medications, and offering comprehensive support strategies. This initiative underlines NASM’s commitment to equipping trainers with evidence-based knowledge for improved client care.
In conclusion, NASM’s new course empowers fitness and wellness professionals with in-depth knowledge about weight loss medications, specifically GLP-1 and GIP. By understanding the nuances of these medications, trainers can enhance their support for clients, fostering safer and healthier weight loss strategies. This initiative reflects NASM’s dedication to providing scientifically-backed resources to boost client well-being in an evolving healthcare landscape.
Original Source: www.globenewswire.com
